K Health raised $50M in equity funding led by Claure Group and Pablo Legorreta to improve access to high-quality primary care with AI technology.
K Health raised $50M in equity funding led by Claure Group and Pablo Legorreta to improve access to high-quality primary care with AI technology.
07/01/24, 4:11 PM
Location
new yorkMoney raised
$50 million
Industry
medical
health care
Investors
Atreides Management, Lp, Valor Equity Partners, Mangrove Capital Partners, Pablo Legorreta, Claure Group
K Health, the leading AI Primary Care platform, has announced a $50M equity funding round led by Claure Group, with participation from investors including Pablo Legorreta, founder and CEO of Royalty Pharma, and existing investors Mangrove Capital Partners, Valor Equity Partners, and Atreides Management, LP. The funding will be used to improve access to high-quality primary care through AI technology, addressing the challenges of physician supply and fragmentation from point solutions.
Company Info
Location
new york, new york, united states
Additional Info
K Health is the AI-driven Primary Care company on a mission to provide access to high-quality medical care at scale. Its 24/7 virtual primary care solution is available to millions of people in the U.S. through leading health systems and insurers, as well as through a direct-to-consumer mobile app. K Health’s platform includes a medical chat and AI predictive models based on large datasets to help physicians optimize diagnosis and treatment, and focus on patient care. K Health is backed by leading investors including Valor Equity Partners, Mangrove Capital Partners, GGV Capital, 14W, Comcast Ventures, Lerer Hippeau, Primary Venture Partners, and PICO Capital Partners.